Collimator Face Research Articles

Measuring the Mutual Effects of a CZT Detector and a 3T MRI for the Development of a Simultaneous MBI/MRI Insert

A cadmium zinc telluride (CZT) based detector system has been developed with the goal of combining molecular breast imaging (MBI) and magnetic resonance imaging (MRI) to address shortcomings of each modality. The CZT detector system is comprised of four CZT modules tiled in a $2\times 2$ array. Each module consists of 256 pixels ( $16\times 16$ , 2.4 mm pixels) and features a built-in ASIC and FPGA. A custom digital readout circuit board was designed to interface the four modules with a microcontroller to a data acquisition PC. The system was placed within the bore of a 3 T GE Discovery MR750 and imaging performance of each modality evaluated using both sequential and simultaneous imaging protocols. The mean energy resolution of the gamma camera both inside and outside the MRI is 7.3% at 140 keV. The maximum increase in the integral uniformity was 3% when using a gradient echo MRI sequence while the mean differential uniformity when inside the MRI increased by 1%. Spatial resolution varied in a predictable manner from 2.4 mm FWHM at the collimator face to 6.9 mm at 10 cm from the collimator. Performance of the 3 T GE Discovery MR750 using a 16-channel breast RF coil array was measured with and without the gamma camera present using a gradient echo and spoiled gradient echo imaging sequence. A realistic 99mTc-filled breast-like phantom containing two lesions (30:1 lesion to background ratio) was used to assess the feasibility of both serial and simultaneous hybrid imaging. Sequential imaging resulted in a reduction in MRI SNR of 70-80% and a further decrease of 93-98% was observed when performing simultaneous MR/scintigraphy imaging, likely a result of RF interference originating from the CZT detector modules and associated analog electronics. Co-registered scintigraphic and MRI images display negligible geometric distortion when imaged with both simultaneous and serial imaging modes, thus indicating the feasibility of combining MBI with breast MRI.

Introduction of a novel ultrahigh sensitivity collimator for brain SPECT imaging.

Noise levels of brain SPECT images are highest in central regions, due to preferential attenuation of photons emitted from deep structures. To address this problem, the authors have designed a novel collimator for brain SPECT imaging that yields greatly increased sensitivity near the center of the brain without loss of resolution. This hybrid collimator consisted of ultrashort cone-beam holes in the central regions and slant-holes in the periphery (USCB). We evaluated this collimator for quantitative brain imaging tasks. Owing to the uniqueness of the USCB collimation, the hole pattern required substantial variations in collimator parameters. To utilize the lead-casting technique, the authors designed two supporting plates to position about 37 000 hexagonal, slightly tapered pins. The holes in the supporting plates were modeled to yield the desired focal length, hole length, and septal thickness. To determine the properties of the manufactured collimator and to compute the system matrix, the authors prepared an array of point sources that covered the entire detector area. Each point source contained 32 μCi of Tc-99m at the first scan time. The array was imaged for 5 min at each of the 64 shifted locations to yield a 2-mm sampling distance, and hole parameters were calculated. The sensitivity was also measured using a point source placed along the central ray at several distances from the collimator face. High-count projection data from a five-compartment brain phantom were acquired with the three collimators on a dual-head SPECT/CT system. The authors calculated Cramer-Rao bounds on the precision of estimates of striatal and background activity concentration. In order to assess the new collimation system to detect changes in striatal activity, the authors evaluated the precision of measuring a 5% decrease in right putamen activity. The authors also reconstructed images of projection data obtained by summing data from the individual phantom compartments. The sensitivity of the novel cone-beam collimator varied with distance from the detector face; it was higher than that of the fan-beam collimator by factors ranging from 2.7 to 162. Examination of the projections of the point sources revealed that only a few holes were distorted or partially blocked, indicating that the intensive manual fabrication process was very successful. Better reconstructed phantom images were obtained from the USCB+FAN collimator pair than from either LEHR or FAN collimation. For the left caudate, located near the center of the brain, the detected counts were 9.8 (8.3) times higher for UCSB compared with LEHR (FAN), averaged over 60 views. The task-specific SNR for detecting a 5% decrease in putamen uptake was 7.4 for USCB and 3.2 for LEHR. The authors have designed and manufactured a novel collimator for brain SPECT imaging. The sensitivity is much higher than that of a fan-beam collimator. Because of differences between the manufactured collimator and its design, reconstruction of the data requires a measured system matrix. The authors have demonstrated the potential of USCB collimation for improved precision in estimating striatal uptake. The novel collimator may be useful for early detection of Parkinson's disease, and for monitoring therapy response and disease progression.

Performance characteristics of dedicated molecular breast imaging systems at low doses.

The purpose of this study was to compare the system performance characteristics and lesion detection capability of two molecular breast imaging (MBI) systems: a multicrystal sodium iodide (NaI)-based single-head system and a cadmium zinc telluride (CZT)-based dual-head system at low administered doses (150-300 MBq) of Tc-99m sestamibi. System performance characteristics including count sensitivity, uniformity, energy resolution, and spatial resolution were measured using standard NEMA methods, or a modified version thereof in cases where the standard NEMA protocol could not be applied. A contrast-detail phantom with 48 lesions at varying depths from the collimator surface was used to assess lesion contrast-to-noise-ratio (CNR) using background count densities comparable to those observed in patient studies performed with administered doses of 150 MBq Tc-99m sestamibi. Lesions with CNR >3 were deemed to be detectable. Thirty patients undergoing MBI examinations with administered doses of 150-300 MBq were scanned for an additional view on the pixelated NaI system. CNR was calculated for lesions observed on patient images. Background count densities of patient images were measured and compared between the two systems. Over the central field of view, integral and differential uniformity were 6.1% and 4.2%, respectively, for the pixelated NaI system, and 3.8% and 2.7%, respectively, for the CZT system. Count sensitivity was 10.8 kcts/min/MBq for the NaI system and 32.9 kcts/min/MBq for the CZT system. Energy resolution was 13.5% on the pixelated NaI system and 4.5% on the CZT system. Spatial resolution (full-width at half-maximum) for the pixelated NaI detector was 4.2 mm at a distance of 1.2 cm from the collimator and 5.2 mm at 3.1 cm. Spatial resolution of a single CZT detector was 2.9 mm at a distance of 1.2 cm from the collimator and 4.7 mm at 3.1 cm. Effective spatial resolution obtained with dual-head CZT was below 4.7 mm throughout a simulated breast thickness of 6 cm. From contrast-detail phantom images of lesions at distances of 1.5-4.5 cm from the collimator face, the CZT system detected 124 of 144 (86%) of lesions compared to 97 of 144 (67%) with the NaI system. In patient studies, from comparison of the same view with both systems, a total of 7 breast lesions were identified on CZT system in seven patients, and 4 of 7 (57%) were detected on NaI system. Patient image background count densities on the CZT system were on average 3.4 times higher than those on the NaI system. The CZT system demonstrated better uniformity, count sensitivity, spatial resolution, energy resolution, and lesion detection in phantom and patient studies compared to the NaI system. At administered doses of 150-300 MBq Tc-99m sestamibi, patient results obtained with CZT systems may not be directly translatable to NaI systems.

An empirical model for calculation of the collimator contamination dose in therapeutic proton beams

Collimators are used as lateral beam shaping devices in proton therapy with passive scattering beam lines. The dose contamination due to collimator scattering can be as high as 10% of the maximum dose and influences calculation of the output factor or monitor units (MU). To date, commercial treatment planning systems generally use a zero-thickness collimator approximation ignoring edge scattering in the aperture collimator and few analytical models have been proposed to take scattering effects into account, mainly limited to the inner collimator face component. The aim of this study was to characterize and model aperture contamination by means of a fast and accurate analytical model. The entrance face collimator scatter distribution was modeled as a 3D secondary dose source. Predicted dose contaminations were compared to measurements and Monte Carlo simulations. Measurements were performed on two different proton beam lines (a fixed horizontal beam line and a gantry beam line) with divergent apertures and for several field sizes and energies. Discrepancies between analytical algorithm dose prediction and measurements were decreased from 10% to 2% using the proposed model. Gamma-index (2%/1 mm) was respected for more than 90% of pixels. The proposed analytical algorithm increases the accuracy of analytical dose calculations with reasonable computation times.

A parallel-cone collimator for high-energy SPECT.

In SPECT using high-energy photon-emitting isotopes, such as (131)I, parallel-hole collimators with thick septa are required to limit septal penetration, at the cost of sensitivity and resolution. This study investigated a parallel-hole collimator with cone-shaped holes, which was designed to limit collimator penetration while preserving resolution and sensitivity. The objective was to demonstrate that a single-slice prototype of the parallel-cone (PC) collimator was capable of improving the image quality of high-energy SPECT. The image quality of the PC collimator was quantitatively compared with that of clinically used low-energy high-resolution (LEHR; for (99m)Tc) and high-energy general-purpose (HEGP; for (131)I and (18)F) parallel-hole collimators. First, Monte Carlo simulations of single and double point sources were performed to assess sensitivity and resolution by comparing point-spread functions (PSFs). Second, a prototype PC collimator was used in an experimental phantom study to assess and compare contrast recovery coefficients and image noise. Monte Carlo simulations showed reduced broadening of the PSF due to collimator penetration for the PC collimator as compared with the HEGP collimator (e.g., 0.9 vs. 1.4 cm in full width at half maximum for (131)I). Simulated double point sources placed 2 cm apart were separately detectable for the PC collimator, whereas this was not the case for (131)I and (18)F at distances from the collimator face of 10 cm or more for the HEGP collimator. The sensitivity, measured over the simulated profiles as the total amount of counts per decay, was found to be higher for the LEHR and HEGP collimators than for the PC collimator (e.g., 3.1 × 10(-5) vs. 2.9 × 10(-5) counts per decay for (131)I). However, at equal noise level, phantom measurements showed that contrast recovery coefficients were similar for the PC and LEHR collimators for (99m)Tc but that the PC collimator significantly improved the contrast recovery coefficients as compared with the HEGP collimator for (131)I and (18)F. High-energy SPECT imaging with a single-slice prototype of the proposed PC collimator has shown the potential for significantly improved image quality in comparison with standard parallel-hole collimators.

SU-C-9A-07: Fabrication and Calibration of a Novel High-Sensitivity Collimator for Brain SPECT Imaging

Purpose: We have designed a novel collimator for brain SPECT imaging that yields greatly increased sensitivity near the center of the brain without loss of resolution. The collimator was manufactured and initial evaluation has been completed. Methods: The collimator was time-consuming and challenging to build. Because our desired hole pattern required substantial variations in hole angle, we designed two supporting plates to securely position about 34,000 hexagonal, slightly tapered, 75-mm long steel pins. The holes in the plates were modeled to yield the desired focal length, hole length and septal thickness. Molten lead was poured in between the plates, and all pins were removed after cooling. The sensitivity gain compared to a fan-beam collimator was measured using a point source placed along the central ray at several distances from the collimator face. Visual inspection of the holes was not possible as the collimator was sealed so it could be safely mounted on a SPECT system. Therefore, we prepared a 2D array of 768, ∼48μCi Tc-99m point sources, separated by 1.6 cm. The array was imaged for 10 minutes at 4 shifted locations to reduce sampling distance to 8 mm. Results: The sensitivity of the novel cone-beam collimator varied with distancemore » from the detector face; it was higher than that of the fan-beam collimator by factors ranging from 3 to 176. Examination of the projections of the 4×768 point sources revealed that fewer than 2% of the holes were fully or partially blocked, which indicates that the intensive manual fabrication process was very successful. Conclusion: We have designed and manufactured a novel collimator for brain SPECT imaging. As expected, the sensitivity is much higher than that of a fan-beam collimator. Because of differences between the manufactured collimator and its design, reconstruction of the data will require a measured system function.« less

The Precise Methods for the Measurement of Collimator Hole Angulation and Center of Rotation of SPECT by Adaptive Quality Control Phantom

The Adaptive Quality Control Phantom (AQCP) is a computer-controlled phantom which positions and moves a radioactive source in the Field of View (FOV) of an imaging nuclear medicine device on a definite path to produce a spatial distribution of gamma rays to perform QC Tests such as the Collimator Hole Angulation (CHA) and the Center of Rotation (COR) of Single Photon Emission Computer Tomography (SPECT). The collimator hole angulation for six collimators was measured using a point source and a computer-controlled cylindrical positioning system. In this method, the displacement of the image of a point source was examined as the AQCP was moving point source vertically away from the collimator face. The results of the high-accuracy measurement method of CHA show that the measurement accuracy for absolute angulation errors is better than ±0.024°. The Root Mean Square (RMS) of CHA for LEHR, LEHS and LEUHR collimators of SMV dual heads camera and LEGP, MEGP and HEGP of GE Millennium MG were evaluated to be 0.290°, 0.292°, 0.208°, 0.154°, 0.220° and 0.202°, respectively. It is to be added in this connection that the evaluated RMS of CHA for LEHR collimator with the distance variation from the collimator’s surface ±1 mm has been varied ±0.04 degree. A new method for the center of rotation assessment by AQCP is introduced and the results of this proposed method as compared with the routine QC test and their differences are discussed in detail. We defined and measured a new parameter called Dynamic Mechanical Error (DME) for applying the gantry motion correction.

Design and performance of a small-animal imaging system using synthetic collimation

This work outlines the design and construction of a single-photon emission computed tomography imaging system based on the concept of synthetic collimation. A focused multi-pinhole collimator is constructed using rapid-prototyping and casting techniques. The collimator projects the centre of the field of view (FOV) through 46 pinholes when the detector is adjacent to the collimator, with the number reducing towards the edge of the FOV. The detector is then moved further from the collimator to increase the magnification of the system. The object distance remains constant, and each new detector distance is a new system configuration. The level of overlap of the pinhole projections increases as the system magnification increases, but the number of projections subtended by the detector is reduced. There is no rotation in the system; a single tomographic angle is used in each system configuration. Image reconstruction is performed using maximum-likelihood expectation–maximization and an experimentally measured system matrix. The system matrix is measured for each configuration on a coarse grid, using a point source. The pinholes are individually identified and tracked, and a Gaussian fit is made to each projection. The coefficients of these fits are used to interpolate the system matrix. The system is validated experimentally with a hot-rod phantom. The Fourier crosstalk matrix is also measured to provide an estimate of the average spatial resolution along each axis over the entire FOV. The 3D synthetic-collimator image is formed by estimating the activity distribution within the FOV and summing the activities in the voxels along the axis perpendicular to the collimator face.

Collimator design for a dedicated molecular breast imaging‐guided biopsy system: Proof‐of‐concept

Molecular breast imaging (MBI) is a dedicated nuclear medicine breast imaging modality that employs dual-head cadmium zinc telluride (CZT) gamma cameras to functionally detect breast cancer. MBI has been shown to detect breast cancers otherwise occult on mammography and ultrasound. Currently, a MBI-guided biopsy system does not exist to biopsy such lesions. Our objective was to consider the utility of a novel conical slant-hole (CSH) collimator for rapid (<1 min) and accurate monitoring of lesion position to serve as part of a MBI-guided biopsy system. An initial CSH collimator design was derived from the dimensions of a parallel-hole collimator optimized for MBI performed with dual-head CZT gamma cameras. The parameters of the CSH collimator included the collimator height, cone slant angle, thickness of septa and cones of the collimator, and the annular areas exposed at the base of the cones. These parameters were varied within the geometric constraints of the MBI system to create several potential CSH collimator designs. The CSH collimator designs were evaluated using Monte Carlo simulations. The model included a breast compressed to a thickness of 6 cm with a 1-cm diameter lesion located 3 cm from the collimator face. The number of particles simulated was chosen to represent the count density of a low-dose, screening MBI study acquired with the parallel-hole collimator for 10 min after a ∼150 MBq (4 mCi) injection of Tc-99m sestamibi. The same number of particles was used for the CSH collimator simulations. In the resulting simulated images, the count sensitivity, spatial resolution, and accuracy of the lesion depth determined from the lesion profile width were evaluated. The CSH collimator design with default parameters derived from the optimal parallel-hole collimator provided 1-min images with error in the lesion depth estimation of 1.1 ± 0.7 mm and over 21 times the lesion count sensitivity relative to 1-min images acquired with the current parallel-hole collimator. Sensitivity was increased via more vertical cone slant angles, larger annular areas, thinner cone walls, shorter cone heights, and thinner radiating septa. Full width at half maximum trended in the opposite direction as sensitivity for all parameters. There was less error in the depth estimates for less vertical slant angles, smaller annular areas, thinner cone walls, cone heights near 1 cm, and generally thinner radiating septa. A Monte Carlo model was used to demonstrate the feasibility of a CSH collimator design for rapid biopsy application in molecular breast imaging. Specifically, lesion depth of a 1-cm diameter lesion positioned in the center of a typical breast can be estimated with error of less than 2 mm using circumferential count profiles of images acquired in 1 min.

Proof of concept for low‐dose molecular breast imaging with a dual‐head CZT gamma camera. Part I. Evaluation in phantoms

Molecular breast imaging (MBI) is a nuclear medicine technology that uses dual-head cadmium zinc telluride (CZT) gamma cameras to image functional uptake of a radiotracer, Tc-99m sestamibi, in the breast. An important factor in adoption of MBI in the screening setting is reduction of the necessary administered dose of Tc-99m sestamibi from the typically used dose of 740 MBq to approximately 148 MBq, such that MBI's whole-body effective dose is comparable to that of screening mammography. Methods that increase MBI count sensitivity may allow a proportional reduction in the necessary administered dose. Our objective was to evaluate the impact of two count sensitivity improvement methods on image quality by evaluating count sensitivity, spatial resolution, and lesion contrast in phantom simulations. Two dual-head CZT-based MBI systems were studied: LumaGem and Discovery NM 750b. Two count sensitivity improvement methods were implemented: registered collimators optimized for dedicated breast imaging and widened energy acceptance window optimized for use with CZT. System sensitivity, spatial resolution, and tumor contrast-to-noise ratio (CNR) were measured comparing standard collimation and energy window setting [126-154 keV (+10%, -10%)] with optimal collimation and a wide energy window [110-154 keV (+10%, -21%)]. Compared to the standard collimator designs and energy windows for these two systems, use of registered optimized collimation and wide energy window increased system sensitivity by a factor of 2.8-3.6. Spatial resolution decreased slightly for both systems with new collimation. At 3 cm from the collimator face, LumaGem's spatial resolution was 4.8 and 5.6 mm with standard and optimized collimation; Discovery NM 750b's spatial resolution was 4.4 and 4.6 mm with standard and optimized collimation, respectively. For both systems, at tumor depths of 1 and 3 cm, use of optimized collimation and wide energy window significantly improved CNR compared to standard settings for tumors 8.0 and 9.2 mm in diameter. At the closer depth of 1 cm, optimized collimation and wide energy window also significantly improved CNR for 5.9 mm tumors on Discovery NM 750b. Registered optimized collimation and wide energy window yield a substantial gain in count sensitivity and measurable gain in CNR, with some loss in spatial resolution compared to the standard collimator designs and energy windows used on these two systems. At low-count densities calculated to represent doses of 148 MBq, this tradeoff results in adequate count density and lesion contrast for detection of lesions ≥8 mm in the middle of a typical breast (3 cm deep) and lesions ≥6 mm close to the collimator (1 cm deep).

Results of the Measurement of the Collimator Hole Angulation for Different Collimators of SPECT with Adaptive Quality Control Phantom

The Adaptive Quality Control Phantom (AQCP) is the computer-controlled phantom which positions and moves a radioactive source in the Field of View (FOV) of an imaging nuclear medicine device on a definite path to produce any spatial distribution of gamma rays to perform the QC Tests such as the Collimator Hole Angulation (CHA) of Single Photon Emission Computer Tomography (SPECT). The collimator hole angulation for seven collimators were measured with the method by using a point source and computer-controlled cylindrical positioning. In this method the displacement of the image of a point source examined as the AQCP move point source vertically away from the collimator face. The results of the high-accuracy measurement method of CHA show that the measurement accuracy for absolute angulation errors is better than ±0.024°. The Root Mean Square (RMS) of CHA for LEHR, LEHS, LEUHR, MEGP-250, MEGP-300, MEGP-360 and HEPH collimators of SMV dual heads camera were measured to be 0.290°, 0.292°, 0.208°, 0.194°, 0.181°, 0.177°, 0.150°, respectively. The Root Mean Square (RMS) of CHA for LEGP, MEGP and HEGP collimators of GE Millennium MG were measured to be 0.154°, 0.220° and 0.202° respectively. It is to be added in this connection that the measured RMS of CHA for LEHR collimator with the distance variation from the collimator’s surface +/– 1 mm has been varied +/– 0.04 degree.

Hot and cold contrasts in high-resolution Tc-99m planar scintigraphy: A survey of fifty-two camera heads using the PICKER thyroid phantom

This study was aimed at comparing the sensitivity and hot and cold contrasts obtained when imaging the PICKER thyroid phantom using gamma cameras fitted with either their ultra-high or high-resolution low-energy parallel hole collimator. Seventeen camera models from Elscint, General Electric, Siemens and Sopha Medical Vision were involved in the study for a total of 30 cameras and 52 camera heads. A single operator conducted the study in order to minimize the impact of human factors. The phantom contained about 74 MBq 99mTc and was imaged at 10 cm from the collimator face with the energy window that are recommended by the camera manufacturer. A total of 1 million counts were accumulated. Hot and cold contrasts were in mean of about 0.05 higher when using an ultra-high-resolution than when using a high-resolution low-energy collimator. This higher contrast was obtained at the expense of a mean reduction in sensitivity of 30%. In particular, Elscint cameras demonstrated a 30% lower sensitivity whatever the collimator type. The Sopha Medical Vision DST and DSX cameras and the General Electric Magicam camera offered the lowest contrasts among the cameras with a high-resolution collimator. Although this was accompanied by a higher than the mean sensitivity for the DST and DSX, the Magicam demonstrated sensitivity roughly identical to the mean of all the cameras with a high-resolution collimator.

Design of optimal collimation for dedicated molecular breast imaging systems.

Molecular breast imaging (MBI) is a functional imaging technique that uses specialized small field-of-view gamma cameras to detect the preferential uptake of a radiotracer in breast lesions. MBI has potential to be a useful adjunct method to screening mammography for the detection of occult breast cancer. However, a current limitation of MBI is the high radiation dose (a factor of 7-10 times that of screening mammography) associated with current technology. The purpose of this study was to optimize the gamma camera collimation with the aim of improving sensitivity while retaining adequate resolution for the detection of sub-10-mm lesions. Square-hole collimators with holes matched to the pixilated cadmium zinc telluride detector elements of the MBI system were designed. Data from MBI patient studies and parameters of existing dual-head MBI systems were used to guide the range of desired collimator resolutions, source-to-collimator distances, pixel sizes, and collimator materials that were examined. General equations describing collimator performance for a conventional gamma camera were used in the design process along with several important adjustments to account for the specialized imaging geometry of the MBI system. Both theoretical calculations and a Monte Carlo model were used to measure the geometric efficiency (or sensitivity) and resolution of each designed collimator. Results showed that through optimal collimation, collimator sensitivity could be improved by factors of 1.5-3.2, while maintaining a collimator resolution of either < or =5 or < or = 7.5 mm at a distance of 3 cm from the collimator face. These gains in collimator sensitivity permit an inversely proportional drop in the required dose to perform

Design of Floating-Boundary Multi-Zone Scintillation Camera With Pileup Prevention and Misplaced Pileup Suppression (MPS)

Image quality in nuclear medicine is a trade-off between image contrast and resolution, since there are conflicting requirements of crystal thickness and collimator-hole dimensions. The sensitivity, or efficiency, which determines the contrast-to-noise ratio, however, is constrained primarily by pulse-mode operation, in which gamma ray interactions are recorded once every deadtime period. Nuclear images also suffer from image blurring due to gamma rays penetrating the collimator septa and due to misplaced pileup events arising from the coincidence detection of Compton-scattered gamma rays. Multi-zone detector architecture (MZDA) and the use of pileup prevention circuitry (PPC) lead to reduction of the detector's effective deadtime, and hence to significant extension of the count-rate range of the camera. This in turn allows the source activity to be increased to make up for sensitivity that will be lost on changing the detector and collimator-hole dimensions to improve spatial resolution. Misplaced pileup suppression (MPS) circuitry, also described in this paper, enables image blurring from Compton-scattered radiation to be reduced to 1/P of its level in a single zone detector, P being the PMT array size. The paper first develops the theoretical relationships relating to the trade-offs between efficiency and resolution, the distribution of scintillation light from interaction points in the crystal, the share of the light exposure of individual PMTs and of clusters of PMTs, and the cross-talk between clusters of PMTs. The paper then presents an outline of the implementation of an S-zone camera with PPC of order 1, based on hexagonal and rectangular arrays of PMTs. A hexagonal array of 331 1.27-cm PMTs, which will have S ap 35 detector-zones on average, can, for instance, use a 1.7-mm thick and 29-cm diameter NaI(Tl) crystal to design a camera with twice the sensitivity of a single-zone camera of the same array size, which will also provide a spatial resolution of 2.1 mm at the collimator face and 3.4 mm at 10 cm from the collimator face.

Quantification of lesion size, depth, and uptake using a dual‐head molecular breast imaging system

A method to perform quantitative lesion analysis in molecular breast imaging (MBI) was developed using the opposing views from a novel dual-head dedicated gamma camera. Monte Carlo simulations and phantom models were used to simulate MBI images with known lesion parameters. A relationship between the full widths at 25%, 35%, and 50% of the maximum of intensity profiles through lesions and the true lesion diameter as a function of compressed breast thickness was developed in order to measure lesion diameter. Using knowledge of compressed breast thickness and the attenuation of gamma rays in soft tissue, a method was developed to measure the depth of the lesion to the collimator face. Using the measured lesion diameter and measurements of counts in the lesion and background breast region, relative radiotracer uptake or tumor to background ratio (T/B ratio) was calculated. Validation of the methods showed that the size, depth, and T/B ratio can be accurately measured for a range of small breast lesions with T/B ratios between 10:1 and 40:1 in breasts with compressed thicknesses between 4 and 10 cm. Future applications of this work include providing information about lesion location in patients for performing a biopsy of site and the development of a threshold for the T/B ratio that can distinguish benign from malignant disease.

Effect of Collimator Selection on Tumor Detection for Dedicated Nuclear Breast Imaging Systems

The effect of collimation on the detection of small (<1 cm) breast tumors with dedicated nuclear breast imaging systems was determined. A breast phantom modeling tumors 4-9 mm in diameter was imaged with three dedicated systems (GE Medical Prototype CZT, Gamma Medica LumaGEM 3200 s, and Digirad 2020 tc), and a conventional gamma camera (Elscint Helix) using a variety of system-specific and generic collimators ranging from LEUHS to LEUHR. Acquisitions were performed using clinically relevant count densities determined from analysis of patient exams. Tumors were placed at depths of 1, 3, and 5 cm from the collimator in a 6-cm-thick breast, and tumor-to-background ratio was varied from 3:1 to 35:1. Tumor signal-to-noise ratio (SNR) was measured in each image. SNR measurements showed that an all-purpose or high sensitivity collimator is optimal for the detection of small tumors close to the collimator face. The three pixilated systems gave similar results and performed significantly better than the conventional gamma camera

Molecular breast imaging—A phantom study on the impact of collimator selection on the detection of sub-10 mm breast lesions

Molecular breast imaging (MBI) with a dedicated breast gamma camera system can detect small breast lesions with a sensitivity of >85%. The objective of this study was to determine the optimal collimation for tumor detection based on count densities obtained from clinical MBI studies. Seven collimators were evaluated using a cadmium zinc telluride detector designed for breast imaging. These included LEUHR, LEHR, LEGP, LEHS, and LEUHS collimators and two system-specific collimators—a long bore (LB) and general-purpose (GP) collimator with square holes matched to the detector elements. Collimators were evaluated using a breast phantom comprising a 20×20×20 cm plastic box containing 16 glass “tumors” with internal diameters ranging from 4–10 mm. Breast thickness was set to 6 cm and tumor depth was varied from 1–5 cm. The phantom and spheres were filled with water and Tc-99m to give a tumor to background ( T/ B) ratio varying from 3:1 to 35:1. Total counts acquired in each image simulated the range of count densities observed clinically. Counts acquired were adjusted to compensate for differences in collimator sensitivity. Tumor signal-to-noise ratio (SNR) was measured through ROI analysis. Images acquired at clinical count densities contained significant amounts of noise, especially at T/ B ratios of 10:1 or less. Highest tumor SNR was obtained with the LEHS collimator for the 6, 8, and 9 mm tumors at depths of 1 and 3 cm. At a tumor depth of 5 cm, the highest SNR was obtained with either the matched GP or LEHS collimators for the 6–9 mm tumors. Low SNR was obtained with all collimators for the 4 mm tumors at 1 and 3 cm and no 4 mm tumors were visible at a depth of 5 cm. High sensitivity collimators may be better than high-resolution collimators for detecting tumors <1 cm in low count images of the breast, especially for tumors located within 1–4 cm of the collimator face, but proper collimator design to eliminate aliasing artifacts is important for pixilated systems.

SU-FF-T-49: A QA Test to Check MLC Carriage Calibration

Purpose: The leaf span for a Varian MLC is 15 cm. Fields larger than this in the leaf motion direction must be split into multiple ports with a “carriage shift” between ports. Leaf position is a function of both carriage position and leaf position within the carriage. The carriage position is dictated by the outermost leaf position, and the carriages do not move during radiation delivery. We have developed a test to assess carriage positioning accuracy by comparing the same abutting MLC‐shaped fields both with and without carriage motion between the delivery of the two fields. Methods and Materials: A 14 cm wide × 40 cm long field was split into two 7 cm wide rectangular ports shaped by the MLC. Width is defined in the leaf motion direction. These two fields were delivered using two separate static MLC files, then using a single DMLC file. In the former case, the carriages move while the leaves remain stationary with respect to the carriages. In the latter case, the carriages remain stationary while the leaves move with respect to the carriages. Kodak XV film was taped to the collimator face for both cases and compared. Results: Both films appeared identical upon visual inspection. A quantitative analysis of the profiles was performed using the RIT software system. Comparison of the profiles revealed that the FWHM of the abutting region agreed to within 0.2 mm between the two films. Conclusion: If accuracy of leaf calibration has been demonstrated, differences between these profiles would imply carriage miscalibration. Carriage miscalibration would result in mispositioning of all leaves within the carriage, thereby causing significant dose delivery errors. This carriage calibration test could be performed routinely as part of the QA procedure for MLCs used for IMRT delivery.

SU‐DD‐A2‐05: Quality Assurance Methodology to Monitor Patient Dose in Interventional Radiography

Purpose: The purpose of this preliminary quality assurance project is to use thermoluminescent dosimeters (TLD) to monitor the equivalent dose patients receive while undergoing interventional radiology procedures at our institution. Method and Materials: A TLD is placed centrally on the collimator face of two AP tubes in the angiography department for each patient exam. The TLDs are sent out weekly to be read by Landauer, Inc. Inverse square correction is applied to yield patient equivalent dose at the minimum and maximum possible distances to the patient entrance surface (source‐to‐skin distance, SSD). The inverse square corrected results are entered into a database and analyzed according to exam type and radiation dose threshold categories. All exams having an equivalent dose of greater than 2 Gy (skin erythema threshold) are red‐flagged in the database. These red‐flagged exams are then shared with the angiography section chief radiologist and technologist for feedback and corrective action with the attending physician. Results: Of the 1852 exams surveyed (from July 2003 through the present time), the equivalent dose for minimum SSD was less than 1 Gy for 94.0% of the exams and between 1 and 2 Gy for 2.6% of the exams. The skin erythema threshold dose of 2 Gy was exceeded for 3.1% of exams throughout this time period. It is encouraging that over 96% of measured equivalent dose are below the skin erythema threshold. The remaining 4% of measured equivalent dose were red‐flagged for follow‐up with the physicians responsible for the exam. Conclusions: This preliminary quality assurance and feedback mechanism is a quick and practical way to increase physician awareness of administered patient dose and whether skin injury dose thresholds have been exceeded. It is expected that this monitoring methodology will encourage physicians to practice ALARA.

Comparison of small field of view gamma camera systems for scintimammography

To compare the performance characteristics of three compact gamma camera systems for scintimammography. A multi-crystal NaI system (Dilon 6800), a multicrystal CsI system (Digirad 2020tc Imager) and a prototype cadmium zinc telluride (CZT) detector were evaluated using a breast phantom with simulated tumours of 1.8-9.8 mm in diameter and a tumour to background ratio of 5.6 : 1. A conventional Anger-based gamma camera was also evaluated for comparative purposes. The conventional gamma camera had the highest intrinsic sensitivity of the four systems and utilized the highest resolution collimator. However, the prototype CZT and the CsI systems yielded the best spatial resolution over the range 0-5 cm from the collimator face and better visualized small (5-7 mm) tumours. In addition to the advantage of close proximity to the breast, two of the three compact detectors offered superior performance to a conventional gamma camera for scintimammography.